Armata Pharmaceuticals (ARMP) Capital Expenditures (2013 - 2026)
Armata Pharmaceuticals (ARMP) reported Capital Expenditures of $63000.0 for Q1 2026, down 36.36% on a YoY basis from $99000.0 in Q1 2025, and up 21.15% sequentially from $52000.0 in Q4 2025.
Armata Pharmaceuticals (ARMP) Capital Expenditures (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 14 years of Capital Expenditures data on file, last reported at $63000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 36.36% year-over-year to $63000.0; the trailing twelve-month figure through Mar 2026 stood at $506000.0 (down 70.72% YoY), and the FY2025 full-year result was $542000.0, down 71.15% from the prior year.
- Capital Expenditures climbed to $63000.0 in Q1 2026, from $52000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $3.5 million in Q3 2023 to a low of -$455000.0 in Q4 2022.
- A 5-year average of $755235.3 and a median of $242000.0 in 2025 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures plunged 299.56% in 2022 and soared 751.69% in 2023, its largest moves.
- Tracing ARMP's Capital Expenditures over 5 years: stood at -$455000.0 in 2022, then surged by 627.47% to $2.4 million in 2023, then tumbled by 103.21% to -$77000.0 in 2024, then soared by 167.53% to $52000.0 in 2025, then advanced by 21.15% to $63000.0 in 2026.
- Business Quant data shows ARMP's Capital Expenditures at $63000.0 in Q1 2026, $52000.0 in Q4 2025, and $242000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - | 63,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63,000.00 |
| Mar 31, 2026 | 63,000.00 |
| Dec 31, 2025 | 52,000.00 |
| Dec 31, 2025 | 52,000.00 |
| Sep 30, 2025 | 242,000.00 |
| Sep 30, 2025 | 242,000.00 |
| Jun 30, 2025 | 149,000.00 |
| Jun 30, 2025 | 149,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Dec 31, 2024 | -77,000.00 |
| Dec 31, 2024 | -77,000.00 |
| Sep 30, 2024 | 340,000.00 |
| Sep 30, 2024 | 340,000.00 |
| Jun 30, 2024 | 1.37 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Mar 31, 2024 | 250,000.00 |
| Mar 31, 2024 | 250,000.00 |
| Dec 31, 2023 | 2.40 Mn |
| Dec 31, 2023 | 2.40 Mn |